Vikas Kumar, Addepalli Veeranjaneyulu
November 27, 2017
by Apple Academic Press
Reference - 312 Pages - 10 Color & 11 B/W Illustrations
ISBN 9781771885881 - CAT# N11902
SAVE ~$31.99 on each
This new volume provides a plethora of new information about potential medicinal herbs and their usefulness in treating diabetes and neurological diseases. Most large multinational companies are interested and engaged in the commercialization of herb-based formulations, and consumers continue to seek natural-based therapies.
Herbs for Diabetes and Neurological Disease Management provides insight into plant-based novel molecules targeted for diabetes and neurological disorders. It looks at a selection of herbs that have proven effective in the management of diabetes and neurological disorders, including migraine, epilepsy, memory disorders, depression, and more. Divided into ten chapters focusing on diabetes and its macro- and microvascular complications (migraine, epilepsy, memory disorders, depression and other neuropsychiatric disorders), this book is structured to provide a source of reliable information and enrich the knowledge of readers. Each chapter briefly explains the epidemiology and pathophysiology of the disease state and the possible role of herbal drugs in the prevention of the particular disease. The reported pharmacological activities and possible mechanism of action of herbal drugs are also discussed in detail, which makes this book informative and unique.
This new volume will be a reliable reference complementing the substantial information on the use of herbal drugs in diabetes and neurological disorders that serve as the pillars of drug discovery and development.
Role of St.-John’s Wort (Hypericum perforatum L.) in the Management of Diabetes and Neurological Disorders
Yusuf Ozturk, Ozgur Devrim Can, and Umide Demir-Ozkay
A Potential Natural Product Combination Targeting Memory Disorders
Manju Bhaskar, Meena Chintamaneni, and Veeranjaneyulu Addepalli
Phytotherapeutic Agents in Epilepsy
Herbal Medicines in Neuropsychiatric Illness: The Case of L-Stepholidine
Nitin Sati, Kedar S. Prabhavalkar, Sridhar N., and Lokesh K. Bhatt
Potential of Curcuma longa and Withania Somnifera for Diabetes and Associated Neurological Comorbidities
Suruchi Verma, Amitabha Dey, and Vikas Kumar
Migraine: Management and Treatment with Herbal Drugs
D. K. Arulmozhi, Yogesh A. Kulkarni, Addepalli Veeranjaneyulu, and R. S. Gaud
Complications of Diabetes and Role of a Citrus Flavonoid Nobiletin in Its Treatment
L. K. Bhatt, N. A. Parkar, V. Addepalli, and R. S. Gaud
Diabetes and Phytopharmaceuticals: Translational Pharmacology Perspective
Priyanka Ingle-Jadhav, Trupti R. Angolkar, and Ginpreet Kaur
Natural Products as Effective Treatment Option for Depression
Yogesh A. Kulkarni, Kalyani H. Barve, and Ginpreet Kaur
Medicinal Plants Research
Mila Emerald and David Marrero
"Our societies find themselves burdened with a growing number of CNS disorders and diabetes, and augmentation of the present therapies by incorporating medicines from natural sources is desirable. Dr. Veeranjaneyulu and Dr. Kumar deserve kudos for putting together this book of thoughtful reviews on plants for treatment of major disorders of central nervous systems and diabetes. Written by several scientists, this book thus fulfills the need for a quick reference and will certainly rekindle interest in this area. . . . This book will be of immense value to researchers in the area and I congratulate both editors for this book."
—From the Foreword by Dr. Madhu Dikshit, FNA, FASc, FNASc, JC Bose National Fellow/Director, CSIR-Central Drug Research Institute, India
"A valuable guide for modern drug hunters and pharmaceutical industries interested in identification of novel pharmacological therapies for meeting the treatment needs of patients suffering from, or at risk of, diabetes and other non-communicable diseases. Information summarized in this book will certainly be very useful in translating the knowledge and knowhow of practitioners of traditionally known systems of medicine in terms of modern molecular sciences. . . . It cannot be overemphasized that such publications are necessary for evolution of experimental evidence-based holistic medicine."
—Dr. Shyam Sunder Chatterjee, Retired Head of Pharmacology Research Laboratories; Dr. Willmar Schwabe GMBH & Co.KG, Karlsruhe, Germany